Vetter Invests in Building an Injectable Drug Production Base in Saarland, Germany
Vetter, a pharmaceutical service provider specializing in injectable drug manufacturing, recently an...
FDA Grants Breakthrough Therapy Designation to Lifileucel for Cutaneous Lupus Erythematosus Treatment
The U.S. Food and Drug Administration (FDA) has officially granted Breakthrough Therapy Designation ...
Hanmi Pharm Signs Exclusive Distribution Agreement with Mexico's Sanfer for Diabetes Drugs
South Korean pharmaceutical company Hanmi Pharm recently entered into an exclusive distribution agre...
FDA Approves New Indication for J&J's Darzalex Faspro in Multiple Myeloma Treatment
The U.S. Food and Drug Administration (FDA) recently approved a new indication for the Darzalex Fasp...
Boehringer Ingelheim Announces Phase II Trial Results for Innovative Drug Apecotrep
German family-owned pharmaceutical company Boehringer Ingelheim today announced the results of the P...
Cellares Secures $257 Million Series D Funding to Advance Cell Therapy Platform Development
San Francisco-based Cellares, which describes itself as the first Integrated Development and Manufac...
Gilead Sciences Drug Receives Top NCCN Guideline Recommendation for Specific Metastatic Breast Cancer Treatment
The American biotechnology company Gilead Sciences announced today that its drug Trodelvy (sacituzum...
Important Progress Made in Breast Cancer Single-Cell Atlas Research
Breast cancer is one of the most common malignant tumors in women and a leading cause of cancer-rela...
Impact of Genes on Lifespan Strengthens with Environmental Changes, New Study Reveals Heritability Can Exceed 50%
A new study published in the journal Science reveals that the influence of genes on human lifespan m...
University of the Philippines Develops Eco-Friendly Silver Nanoparticle Synthesis Technology for Antimicrobial Applications
Researchers from the College of Science at the University of the Philippines Diliman have developed ...